Av
Läkemedelsbolaget lägger ner hela sin verksamhet i Lund och delar av den flyttar istället till Mölndal utanför Göteborg. 900 tjänster påverkas i Lund. I Mölndal kommer bolaget att bedriva forskning och utveckling inom hjärt- och kärlsjukdomar, mag- tarmsjukdomar och inflammationer. Bolaget meddelar enligt svd.se att det är oklart hur anläggningen i Södertälje kommer att påverkas, men att den ska fortsätta att vara centrum för forskning inom neurologi.
Anläggningen i Lund är en ren forskningsanläggning och nedläggningen berör främst tjänstemän.
– Vi har ingen tillverkning alls. Det som är extremt i det här är att det är väldigt många forskare, över 160 disputerade forskare, säger Bo Servenius som är ordförande för Akademikerföreningen vid företaget i Lund, till TT.
Sparpaketet beskrevs i Astrazenecas årsrapport i januari och enligt bolaget kommer de globala neddragningarna att ge besparingar på sju miljarder kronor årligen. Astrazeneca beskrev i rapporten att förutom 3 500 tjänster inom forskning och utveckling kan ytterligare 8 000 personer komma att sägas upp fram till 2014. Av de 3 500 inom FoU kommer den verkliga minskningen globalt att vara 1 800 personer, eftersom bolaget också kommer att göra nysatsningar i framtiden. Dessa kommer dock att göras i USA och Asien. Astrazeneca har 63 000 anställda globalt och 10 400 i Sverige.
Anläggningen i Lund är en ren forskningsanläggning och nedläggningen berör främst tjänstemän.
– Vi har ingen tillverkning alls. Det som är extremt i det här är att det är väldigt många forskare, över 160 disputerade forskare, säger Bo Servenius som är ordförande för Akademikerföreningen vid företaget i Lund, till TT.
Sparpaketet beskrevs i Astrazenecas årsrapport i januari och enligt bolaget kommer de globala neddragningarna att ge besparingar på sju miljarder kronor årligen. Astrazeneca beskrev i rapporten att förutom 3 500 tjänster inom forskning och utveckling kan ytterligare 8 000 personer komma att sägas upp fram till 2014. Av de 3 500 inom FoU kommer den verkliga minskningen globalt att vara 1 800 personer, eftersom bolaget också kommer att göra nysatsningar i framtiden. Dessa kommer dock att göras i USA och Asien. Astrazeneca har 63 000 anställda globalt och 10 400 i Sverige.
"PCG - a professional full service CRO for your clinical trials.
Powered by Viedoc, globally trusted eCRF, keeping trials within budget and timelines" 
"Our services in ligand-based and structure-based drug design is a cost-efficient alternative for smaller pharmaceutical companies" 
"Our goal is to invest in innovations and develop new unique pharmaceuticals" 
"Our reliability, customer service, global network and integrated technology make World Courier service truly "A service no one else can deliver"." 
"Anton Paar is a product and service leader in the field of scientific instruments. We deliver uncompromised quality in everything we do." 
"We are entirely devoted to luminescence technology." 
"Discover your possibilities in one of Europe´s most productive life science regions. Welcome to Stockholm-Uppsala."
" 
"Our aim is to be the best drug development partner to the biotechnology and pharmaceutical industry no matter where you are based." 
"Our vision is to become one of the top 10 global providers of scientific instruments; we will get there by striving for market leadership in our respective product and application niches."
" 
"TFS is today the leading European development partner for biopharmaceutical companies in their global clinical development process." 
"Your global partner of pharmaceutical service and cGMP manufacturing" 
"We offer effective staffing solutions provided by specialists, we understand a company’s specific needs and we know where to find the best talent." 
"We are recognized as a flexible partner with short decision and lead times plus a proven record for the highest quality and cost efficiency." 
"Best in class companies see the value of optimising their business by having an effective strategy for information management and documentation." 
"Allenex is a life science company that develops, manufactures, markets and sells high quality products for the transplantation market." 
"Together with Zacco our clients achieve their business goals through the management of their intellectual property." 
"To develop innovative and effective pharmaceuticals within autoimmune/ inflammatory diseases and cancer where major medical need exists" 
"As a full service CRO with offices in all Nordic countries we can provide our customer with professional support throughout the clinical research." 
"Uppsala BIO is a life science pathfinder. We build ways to make life science flourish, in cooperation with industry, academia, society and healthcare." 
"We aim to be the pioneering benchmark in user-friendly software experience in combination with the highest level of quality." 
"Novel products for CVD treatment and prevention." 
"To be acknowledged as the Best-in-Class provider of pharmaceutical development and manufacturing services by customers, employees & other stakeholders" 
"Our products enable an increased number of transplants leading to substantial cost savings for society and increased quality of life for patients." 
"Our organisation value is to contribute to positioning Scandinavian healthcare and research in absolute world class." 
"Your work is important to us, we are committed to your success.
Innovative tools? Please download the Promega app." 
"We help our clients create significant business value through scientific expertise." 
"We promise to go the extra mile every day to ensure you receive the highest level of service and value with each shipment you entrust to us." 
"We have a unique technological platform, built around 5HT-receptor antagonism, for the treatment of inflammation and pain"." 
"Medivir is a specialty pharmaceutical company with unique positioning on the Nordic market and our goal is become a profitable company in high growth" 
"Innovation takes place when biology meets engineering; ICT is an enabler to solve the needs for increased functionality and reduced cost in Life Science" 
"With our first class products and our committed and skilled colleagues we guarantee our customers the best support in the market, at no extra charge." 
"To become an internationally leading dental company with innovative, proprietary products of high therapeutic and commercial value." 
"APL provides high-quality services to Life Science. We are a Dedicated Partner from Discovery to Market." 
"The PolyPeptide Group is a world class manufacturer of peptide active pharmaceutical ingredients." 
"To supply Swedish and Danish laboratories with laboratory equipment and furniture of highest quality and offer service on all delivered products." 
"To adapt Competent Authorities´ requirements into opportunities is not just an artform - today it´s a business necessity." 
"We are making it more attractive for companies to invest in innovation with reduced corporation tax on profits from patents to 10%." 
"Mercodia has been a supplier of reliable assays since 1991" 
"We turn medical research into applications for better health and well-being." 
"To be the most attractive node and business platform in the Nordic countries for new and innovative Life Science companies" 
"Dilafor is developing new products in the field of obstetrics, to provide an effective solution to the challenge of dystocia or protracted labor"
" 
"VWR is a global laboratory distributor of chemicals, life science products, consumables, equipment, instruments, furniture, e-commerce and services" 
